Northern Trust’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $84.4M | Buy |
1,537,059
+94,480
| +7% | +$3.87M | 0.01% | 894 |
|
|
2026
Q1 | $47.9M | Buy |
1,442,579
+23,060
| +2% | +$687K | 0.01% | 1121 |
|
|
2025
Q4 | $42.3M | Sell |
1,419,519
-82,214
| -5% | -$2.69M | 0.01% | 1214 |
|
|
2025
Q3 | $54.3M | Sell |
1,501,733
-33,990
| -2% | -$1.12M | 0.01% | 1083 |
|
|
2025
Q2 | $55.3M | Buy |
1,535,723
+6,316
| +0.4% | +$235K | 0.01% | 1043 |
|
|
2025
Q1 | $60.3M | Sell |
1,529,407
-3,522
| -0.2% | -$119K | 0.01% | 983 |
|
|
2024
Q4 | $46.1M | Buy |
1,532,929
+120,785
| +9% | +$3.47M | 0.01% | 1177 |
|
|
2024
Q3 | $33M | Buy |
1,412,144
+135,827
| +11% | +$2.97M | 0.01% | 1304 |
|
|
2024
Q2 | $22.7M | Sell |
1,276,317
-24,071
| -2% | -$384K | ﹤0.01% | 1474 |
|
|
2024
Q1 | $19.8M | Sell |
1,300,388
-50,547
| -4% | -$805K | ﹤0.01% | 1601 |
|
|
2023
Q4 | $23.1M | Sell |
1,350,935
-7,063
| -0.5% | -$82.1K | ﹤0.01% | 1513 |
|
|
2023
Q3 | $11.4M | Buy |
1,357,998
+9,198
| +0.7% | +$128K | ﹤0.01% | 1909 |
|
|
2023
Q2 | $33.5M | Buy |
1,348,800
+47,033
| +4% | +$1.21M | 0.01% | 1228 |
|
|
2023
Q1 | $19.6M | Buy |
1,301,767
+30,969
| +2% | +$470K | ﹤0.01% | 1563 |
|
|
2022
Q4 | $15M | Buy |
1,270,798
+16,005
| +1% | +$116K | ﹤0.01% | 1732 |
|
|
2022
Q3 | $7.43M | Buy |
1,254,793
+9,904
| +0.8% | +$65K | ﹤0.01% | 2195 |
|
|
2022
Q2 | $5.29M | Sell |
1,244,889
-7,830
| -0.6% | -$48.9K | ﹤0.01% | 2475 |
|
|
2022
Q1 | $11.9M | Sell |
1,252,719
-56,051
| -4% | -$649K | ﹤0.01% | 2038 |
|
|
2021
Q4 | $24.9M | Sell |
1,308,770
-5,650
| -0.4% | -$147K | ﹤0.01% | 1622 |
|
|
2021
Q3 | $43.7M | Sell |
1,314,420
-49,777
| -4% | -$1.54M | 0.01% | 1185 |
|
|
2021
Q2 | $52.9M | Buy |
1,364,197
+29,604
| +2% | +$1.16M | 0.01% | 1093 |
|
|
2021
Q1 | $64.3M | Sell |
1,334,593
-19,965
| -1% | -$959K | 0.01% | 922 |
|
|
2020
Q4 | $70.5M | Buy |
1,354,558
+9,379
| +0.7% | +$317K | 0.01% | 839 |
|
|
2020
Q3 | $36M | Buy |
1,345,179
+76,923
| +6% | +$1.77M | 0.01% | 1144 |
|
|
2020
Q2 | $24.7M | Buy |
1,268,256
+154,157
| +14% | +$2.48M | 0.01% | 1439 |
|
|
2020
Q1 | $11M | Buy |
1,114,099
+28,794
| +3% | +$364K | ﹤0.01% | 1816 |
|
|
2019
Q4 | $12M | Buy |
1,085,305
+25,195
| +2% | +$192K | ﹤0.01% | 2061 |
|
|
2019
Q3 | $5.95M | Buy |
1,060,110
+216,967
| +26% | +$1.51M | ﹤0.01% | 2456 |
|
|
2019
Q2 | $7.29M | Buy |
843,143
+33,200
| +4% | +$251K | ﹤0.01% | 2343 |
|
|
2019
Q1 | $6.51M | Buy |
809,943
+8,383
| +1% | +$45.3K | ﹤0.01% | 2403 |
|
|
2018
Q4 | $3.29M | Sell |
801,560
-20,879
| -3% | -$104K | ﹤0.01% | 2759 |
|
|
2018
Q3 | $4.61M | Buy |
822,439
+70,714
| +9% | +$808K | ﹤0.01% | 2730 |
|
|
2018
Q2 | $9.88M | Buy |
751,725
+121,424
| +19% | +$1.67M | ﹤0.01% | 2276 |
|
|
2018
Q1 | $8.95M | Buy |
630,301
+12,517
| +2% | +$160K | ﹤0.01% | 2240 |
|
|
2017
Q4 | $5.07M | Buy |
617,784
+20,886
| +3% | +$182K | ﹤0.01% | 2599 |
|
|
2017
Q3 | $7.07M | Sell |
596,898
-1,728
| -0.3% | -$19.7K | ﹤0.01% | 2413 |
|
|
2017
Q2 | $6.02M | Buy |
598,626
+134,463
| +29% | +$1.51M | ﹤0.01% | 2507 |
|
|
2017
Q1 | $5.41M | Buy |
464,163
+5,953
| +1% | +$42.7K | ﹤0.01% | 2513 |
|
|
2016
Q4 | $2.13M | Buy |
458,210
+3,489
| +0.8% | +$20.5K | ﹤0.01% | 3054 |
|
|
2016
Q3 | $3.52M | Sell |
454,721
-5,567
| -1% | -$35.8K | ﹤0.01% | 2760 |
|
|
2016
Q2 | $2.79M | Buy |
460,288
+13,194
| +3% | +$107K | ﹤0.01% | 2849 |
|
|
2016
Q1 | $3.81M | Buy |
447,094
+5,179
| +1% | +$45.3K | ﹤0.01% | 2583 |
|
|
2015
Q4 | $5.27M | Buy |
441,915
+15,552
| +4% | +$196K | ﹤0.01% | 2437 |
|
|
2015
Q3 | $4.3M | Buy |
426,363
+65,723
| +18% | +$979K | ﹤0.01% | 2536 |
|
|
2015
Q2 | $5.98M | Buy |
360,640
+53,437
| +17% | +$846K | ﹤0.01% | 2413 |
|
|
2015
Q1 | $4.76M | Buy |
307,203
+6,712
| +2% | +$102K | ﹤0.01% | 2537 |
|
|
2014
Q4 | $4.76M | Buy |
300,491
+44,482
| +17% | +$579K | ﹤0.01% | 2537 |
|
|
2014
Q3 | $2.73M | Buy |
256,009
+32,717
| +15% | +$303K | ﹤0.01% | 2893 |
|
|
2014
Q2 | $2.1M | Buy |
223,292
+4,864
| +2% | +$31.1K | ﹤0.01% | 3071 |
|
|
2014
Q1 | $1.51M | Buy |
218,428
+5,102
| +2% | +$30.2K | ﹤0.01% | 3264 |
|
|
2013
Q4 | $832K | Buy |
213,326
+10,517
| +5% | +$42.5K | ﹤0.01% | 3430 |
|
|
2013
Q3 | $1.02M | Buy |
202,809
+133,775
| +194% | +$818K | ﹤0.01% | 3322 |
|
|
2013
Q2 | $441K | Buy |
+69,034
| New | +$442K | ﹤0.01% | 3484 |
|
Other funds holding TGTX
SCM
CAM
Northern Trust's TGTX Position: Q2 2026 in Review
Northern Trust increased its TG Therapeutics (TGTX) stake by 6.5% in Q2 2026, buying an estimated $3.87M and bringing the position to 1,537,059 shares worth $84.4M. The position accounts for 0.01% of the portfolio, ranked #894.
Northern Trust first reported a position in TGTX in Q2 2013 and has held it in 53 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Northern Trust held 1,537,059 shares of TG Therapeutics worth $84.4M as of Q2 2026.
- Northern Trust bought 94,480 TG Therapeutics shares in Q2 2026, an estimated $3.87M.
- TG Therapeutics made up 0.01% of Northern Trust's portfolio in Q2 2026, its #894 holding.
- Northern Trust first reported a position in TG Therapeutics in Q2 2013 and has held it in 53 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.